» Articles » PMID: 15742170

Clinical, Histological and Molecular Follow-up of 60 Patients with Gastric Marginal Zone Lymphoma of Mucosa-associated Lymphoid Tissue

Overview
Journal Virchows Arch
Date 2005 Mar 3
PMID 15742170
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

The persistence of gastric lymphoma after Helicobacter pylori eradication may be difficult to evidence on endoscopic and histological examination. The aims of the study were to evaluate the detection of monoclonal immunoglobulin H (IgH) gene rearrangement in endoscopically infiltrated and normal mucosa at diagnosis and during follow-up in order to determine its clinical and prognostic impact. We studied 60 gastric marginal zone lymphomas of mucosa-associated lymphoid tissue (MALT), and IgH monoclonality was detected at diagnosis in 52 patients (87%). The endoscopically normal mucosa contained clonal lymphomatous cells in 69% of cases before remission. A complete histological remission (HR) was observed in 28 patients (47%). Among them, 23 were followed for molecular remission (MR). The median delay was 10 months to achieve HR and 18 months to achieve MR. Interestingly, patients with HR but not MR had a longer delay to achieve HR (21 months) (P=0.0006) and a more frequent clonal normal mucosa at diagnosis (88%) than patients with both HR and MR (10 months and 39%, respectively). The presence of monoclonal B cells at both infiltrated and normal sites may therefore identify patients with a longer delay to achieve complete response, suggesting that molecular dissemination may require therapeutic intensification.

Citing Articles

Clinical Management of Patients with Gastric MALT Lymphoma: A Gastroenterologist's Point of View.

Matysiak-Budnik T, Priadko K, Bossard C, Chapelle N, Ruskone-Fourmestraux A Cancers (Basel). 2023; 15(15).

PMID: 37568627 PMC: 10417821. DOI: 10.3390/cancers15153811.


Helicobacter pylori and Gastric Mucosa-associated Lymphoid Tissue (MALT) Lymphoma: Updated Review of Clinical Outcomes and the Molecular Pathogenesis.

Suzuki H, Saito Y, Hibi T Gut Liver. 2010; 3(2):81-7.

PMID: 20431728 PMC: 2852701. DOI: 10.5009/gnl.2009.3.2.81.


Treatment of low-grade gastric MALT-lymphoma unresponsive to Helicobacter pylori therapy: a pooled-data analysis.

Zullo A, Hassan C, Andriani A, Cristofari F, Bassanelli C, Spinelli G Med Oncol. 2009; 27(2):291-5.

PMID: 19308737 DOI: 10.1007/s12032-009-9207-y.


Helicobacter pylori: present status and future prospects in Japan.

Suzuki H, Hibi T, Marshall B J Gastroenterol. 2007; 42(1):1-15.

PMID: 17322988 PMC: 2780612. DOI: 10.1007/s00535-006-1990-z.


Mucosa-associated lymphoid tissue (MALT) lymphoma: a practical guide for pathologists.

Bacon C, Du M, Dogan A J Clin Pathol. 2006; 60(4):361-72.

PMID: 16950858 PMC: 2001121. DOI: 10.1136/jcp.2005.031146.


References
1.
Bayerdorffer E, Neubauer A, Rudolph B, Thiede C, Lehn N, Eidt S . Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group. Lancet. 1995; 345(8965):1591-4. DOI: 10.1016/s0140-6736(95)90113-2. View

2.
Stolte M, Eidt S . Healing gastric MALT lymphomas by eradicating H pylori?. Lancet. 1993; 342(8871):568. DOI: 10.1016/0140-6736(93)91404-a. View

3.
Savio A, Zamboni G, Capelli P, Negrini R, Santandrea G, Scarpa A . Relapse of low-grade gastric MALT lymphoma after Helicobacter pylori eradication: true relapse or persistence? Long-term post-treatment follow-up of a multicenter trial in the north-east of Italy and evaluation of the diagnostic protocol's adequacy. Recent Results Cancer Res. 2000; 156:116-24. DOI: 10.1007/978-3-642-57054-4_15. View

4.
Montalban C, Santon A, Boixeda D, Redondo C, Alvarez I, Calleja J . Treatment of low grade gastric mucosa-associated lymphoid tissue lymphoma in stage I with Helicobacter pylori eradication. Long-term results after sequential histologic and molecular follow-up. Haematologica. 2001; 86(6):609-17. View

5.
Wotherspoon A, Ortiz-Hidalgo C, Falzon M, Isaacson P . Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet. 1991; 338(8776):1175-6. DOI: 10.1016/0140-6736(91)92035-z. View